Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mandema

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|April 1, 2014
Prediction of clinical irrelevance of PK differences in atorvastatin using PK/PD models derived from literature-based meta-analysesR Vargo, A Adewale, M O Behm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeysS Bowersox, J Mandema, K Tarczy-Hornoch, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2013
Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in PsoriasisM G Dodds, D H Salinger, J Mandema, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 4, 2007
[Anaphylaxis in two children caused by peanut and nut allergies; recommendations for treatment]M M Boeve, B L Rottier, J Mandema, et al.
Clinical Pharmacology and Therapeutics|May 9, 2017
Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-AnalysisT Checchio, S Ahadieh, P Gupta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|April 1, 2014
Prediction of clinical irrelevance of PK differences in atorvastatin using PK/PD models derived from literature-based meta-analysesR Vargo, A Adewale, M O Behm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeysS Bowersox, J Mandema, K Tarczy-Hornoch, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2013
Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in PsoriasisM G Dodds, D H Salinger, J Mandema, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 4, 2007
[Anaphylaxis in two children caused by peanut and nut allergies; recommendations for treatment]M M Boeve, B L Rottier, J Mandema, et al.
Clinical Pharmacology and Therapeutics|May 9, 2017
Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-AnalysisT Checchio, S Ahadieh, P Gupta, et al.
Pageof 1